Leukotrap WB System
Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System
Approved
Approval ID
b2064cb0-542d-41d4-82ef-e7e6a53b9400
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 19, 2023
Manufacturers
FDA
Haemonetics Corporation
DUNS: 057827420
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CPDA-1 Blood Bag Collection System
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code53157-736
Application NumberBN800077
Product Classification
M
Marketing Category
C73594
G
Generic Name
CPDA-1 Blood Bag Collection System
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 19, 2023
FDA Product Classification
INGREDIENTS (5)
DEXTROSE MONOHYDRATEActive
Quantity: 2.01 g in 63 mL
Code: LX22YL083G
Classification: ACTIB
SODIUM CITRATEActive
Quantity: 1.66 g in 63 mL
Code: 1Q73Q2JULR
Classification: ACTIB
CITRIC ACID MONOHYDRATEActive
Quantity: 0.206 g in 63 mL
Code: 2968PHW8QP
Classification: ACTIM
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEActive
Quantity: 0.14 g in 63 mL
Code: 593YOG76RN
Classification: ACTIB
ADENINEActive
Quantity: 0.017 g in 63 mL
Code: JAC85A2161
Classification: ACTIB